UBS Group’s Liminatus Pharma, Inc. Warrants LIMNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$485 Buy
+2,020
New +$485 ﹤0.01% 8487